Literature DB >> 9693191

Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein.

T Matsui1, T Kageshita, T Ishihara, S Tomiguchi, M Takahashi, T Ono.   

Abstract

We describe a 43-year-old Japanese female who developed hypercalcemia associated with malignant melanoma. The patient underwent three resections of tumors on her groin and buttock secondary to a bathing trunk congenital nevus, and the histopathological findings showed benign congenital nevi. At the age of 42 years, she developed a malignant melanoma under the giant pigmented nevus in her groin. Fourteen months after the diagnosis of melanoma, she developed metastases to the lung, para-aortic lymph nodes and bones accompanied by hypercalcemia resulting from a remarkable increase in the serum level of parathyroid hormone-related protein (PTHrP). The patient died from acute renal and respiratory failure. In addition, we analyzed serum levels of calcium and PTHrP in 19 patients with advanced malignant melanoma. Seven patients had hypercalcemia, and 3 had increased serum levels of PTHrP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693191     DOI: 10.1159/000017960

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Serum calcium, albumin and tumor stage in cutaneous malignant melanoma.

Authors:  Mridul Datta; Paul Savage; James Lovato; Gary G Schwartz
Journal:  Future Oncol       Date:  2016-06-16       Impact factor: 3.404

2.  Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates.

Authors:  Teresa Anne Mills; Marlana Orloff; Marina Domingo-Vidal; Paolo Cotzia; Ruth C Birbe; Rossitza Draganova-Tacheva; Maria P Martinez Cantarin; Madalina Tuluc; Ubaldo Martinez-Outschoorn
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.